Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) announced that Dr. Simon Pimstone, CEO, will participate in two upcoming virtual investor conferences. The William Blair Biotech Focus Conference 2020 is scheduled for August 6, 2020, at 12:00 pm ET, focusing on new therapies for epilepsy. The Wedbush PacGrow Healthcare Conference will take place on August 11, 2020, at 3:30 pm ET. All presentations will be available for replay on Xenon's website for 30 days following the events.

BURNABY, British Columbia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer, will participate in the following virtual investor conferences:

• William Blair Biotech Focus Conference 2020 | Panel 4: New Therapies Impacting the Epilepsy Treatment Landscape on Thursday, August 6, 2020 at 12:00 pm ET
   
• 2020 Wedbush PacGrow Healthcare Conference on Tuesday, August 11, 2020 at 3:30 pm ET

The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at www.xenon-pharma.com. All webcasts will be posted for replay following the event for 30 days.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

When is Xenon Pharmaceuticals participating in the William Blair Biotech Focus Conference?

Xenon Pharmaceuticals will participate in the William Blair Biotech Focus Conference on August 6, 2020, at 12:00 pm ET.

What will be discussed at the William Blair Biotech Focus Conference?

The panel at the William Blair Biotech Focus Conference will cover new therapies impacting the epilepsy treatment landscape.

When is the Wedbush PacGrow Healthcare Conference?

The Wedbush PacGrow Healthcare Conference is scheduled for August 11, 2020, at 3:30 pm ET.

How can I access the webcasts from Xenon's conference presentations?

Webcasts of Xenon's conference presentations will be available for replay on their website for 30 days after the events.

What is the main focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals focuses on developing innovative therapeutics for neurological disorders, particularly epilepsy.